INDEMNIFICATION AGREEMENTIndemnification Agreement • October 20th, 2023 • Invea Therapeutics, Inc • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 20th, 2023 Company Industry JurisdictionTHIS INDEMNIFICATION AGREEMENT (the “Agreement”) is made and entered into as of ________________ between Invea Therapeutics, Inc., a Delaware corporation (the “Company”), and ________________ (“Indemnitee”).
AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • October 20th, 2023 • Invea Therapeutics, Inc • Pharmaceutical preparations • Delaware
Contract Type FiledOctober 20th, 2023 Company Industry JurisdictionTHIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of April 7, 2022, by and among Invea Therapeutics, Inc., a Delaware corporation (the “Company”), each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”, each of the stockholders listed on Schedule B hereto, each of whom is referred to herein as a “Key Holder” and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 6.9 hereof.
Invea Therapeutics, Inc. AMENDMENT TO GRID NOTEGrid Note Amendment • October 20th, 2023 • Invea Therapeutics, Inc • Pharmaceutical preparations • Connecticut
Contract Type FiledOctober 20th, 2023 Company Industry JurisdictionThis Amendment to Grid Note, dated October 20, 2023 (the “Amendment”) is entered into by and between Invea Therapeutics., a Delaware corporation (the “Company” or the “Borrower”) and the InveniAI LLC (the “Payee”). Capitalized terms used in this Amendment and not otherwise defined in this Amendment have the respective meanings ascribed to them in the Grid Note (as defined below).
AMENDMENT TO GRID NOTEGrid Note Amendment • October 20th, 2023 • Invea Therapeutics, Inc • Pharmaceutical preparations
Contract Type FiledOctober 20th, 2023 Company IndustryThis Amendment (this “Amendment”), dated as of October 12, 2023 (the “Amendment Effective Date”), is entered into by and between Invea Therapeutics, Inc., a Delaware corporation (the “Payor”), and InveniAl LLC, a Delaware limited liability company (the “Payee”). This Amendment amends that certain Grid Note, dated as of November 24, 2021, by and between Payor and Payee (as it may be further amended, supplemented or modified from time to time, the “Note”). Capitalized terms used herein and not otherwise defined herein shall have the meaning assigned to such terms in the Note.